Article

Neurobiology Underlying Fibromyalgia Symptoms

Alan Edwards Centre for Research on Pain, McGill University, 3640 University Street, Room M19, Montreal, QC, H2A 1C1, Canada.
Pain research and treatment 01/2012; 2012:585419. DOI: 10.1155/2012/585419
Source: PubMed

ABSTRACT Fibromyalgia is characterized by chronic widespread pain, clinical symptoms that include cognitive and sleep disturbances, and other abnormalities such as increased sensitivity to painful stimuli, increased sensitivity to multiple sensory modalities, and altered pain modulatory mechanisms. Here we relate experimental findings of fibromyalgia symptoms to anatomical and functional brain changes. Neuroimaging studies show augmented sensory processing in pain-related areas, which, together with gray matter decreases and neurochemical abnormalities in areas related to pain modulation, supports the psychophysical evidence of altered pain perception and inhibition. Gray matter decreases in areas related to emotional decision making and working memory suggest that cognitive disturbances could be related to brain alterations. Altered levels of neurotransmitters involved in sleep regulation link disordered sleep to neurochemical abnormalities. Thus, current evidence supports the view that at least some fibromyalgia symptoms are associated with brain dysfunctions or alterations, giving the long-held "it is all in your head" view of the disorder a new meaning.

1 Follower
 · 
184 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Patients with fibromyalgia often report forgetfulness as well as declines in cognitive function, memory, and mental alertness-symptoms that have been termed "fibrofog" in popular and electronic media as well as in professional literature. "Fibrofog" is the subjectively experienced cognitive dysfunction associated with fibromyalgia and is a clinically important yet comparatively less well-studied aspect of the disorder; it includes loss of mental clarity (mental fogginess) as well as attention and memory impairment. Although until recently cognitive symptoms have been largely ignored, these symptoms can be more disturbing than the widespread pain and can change these patients' lives, sometimes dramatically so. Whereas widespread musculoskeletal pain, tenderness, and fatigue may be the hallmark symptoms of fibromyalgia, patients rank cognitive dysfunction highly in terms of disease impact. This review addresses (1) the prevalence of self-reported cognitive disturbances in fibromyalgia, (2) the clinical presentation of fibrofog, (3) neuropsychological test performance, with particular attention to discrepancies between self-report and test results, (3) clinical correlates of impaired cognitive function in fibromyalgia, (4) neurobiology relevant to cognitive disturbances in fibromyalgia, and (5) clinical management of fibrofog. Although the pathophysiology of fibromyalgia remains an enigma, evidence suggests that it may be a brain disorder, with cognitive deficits ("fibrofog") reflecting disturbed centrally mediated processes.
    Rheumatology International 01/2015; DOI:10.1007/s00296-014-3208-7 · 1.63 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Previous qualitative research has revealed that people with fibromyalgia use daytime napping as a coping strategy for managing symptoms against clinical advice. Yet there is no evidence to suggest whether daytime napping is beneficial or detrimental for people with fibromyalgia. The purpose of this study is to explore how people use daytime naps and to determine the links between daytime napping and symptom severity in fibromyalgia syndrome. Methods: A community based sample of 1044 adults who had been diagnosed with fibromyalgia syndrome by a clinician completed an online questionnaire. Associations between napping behavior, sleep quality and fibromyalgia symptoms were explored using Spearman correlations, with possible predictors of napping behaviour entered into a logistic regression model. Differences between participants who napped on a daily basis and those who napped less regularly, as well as nap duration were explored. Results: Daytime napping was significantly associated with increased pain, depression, anxiety, fatigue, memory difficulties and sleep problems. Sleep problems and fatigue explained the greatest amount of variance in napping behaviour, p<0.010. Those who engaged in daytime naps for >30 minutes had higher memory difficulties (t=-3.45) and levels of depression (t = -2.50) than those who napped for shorter periods (<30mins) (p<0.010). Conclusions: Frequent use and longer duration of daytime napping was linked with greater symptom severity in people with fibromyalgia. Given the common use of daytime napping in people with fibromyalgia evidence based guidelines on the use of daytime napping in people with chronic pain are urgently needed.
    BMC Musculoskeletal Disorders 01/2015; accepted(1). DOI:10.1186/s12891-015-0464-y · 1.90 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Fibromyalgia (FM) is a prevalent, chronic and disabling disorder, which etiology is unknown. It is characterized by widespread pain, diffuse tenderness, and a plethora of other symptoms. It is also considered the coexistence of tender points – painful points when a digital palpation of 4 kg/A of force is exercised - through the body. Technically, it can be defined as a history of widespread pain for at least 3 months and the existence of pain at least in 11 of 18 tender points. Its manifestations are not homogenous, making the diagnosis difficult. It shows varying proportions of anxiety and depression as comorbidities, which depend on the psychological features of each patient. Therefore, the medical evaluation must not include only the presence/absence of widespread pain or painful tender points, but also the existence of mood changes. Some studies show that the patients with FM have high rates of alexithymia and rage, and link depression, work stress and childhood traumatic events as contributors to its etiology, therefore, antidepressants could be an effective therapeutic handling. On the other hand, researchers have identified the influence of social effort and emotional context under the pain threshold in FM. These and other results led to conclude that there is an intrinsic bind between depressive disorders and FM. Other studiers classified them in a same wide category of stress disturbances. Finally, depression is a frequent (present in 28,6 to 70% of the patients) comorbidity associated with fibromyalgia, and brings worsening to its natural history of disease.
    Fibromyalgia: Risk Factors, Symptoms and Treatment, 01/2013: chapter Fibromyalgia: The Role of Antidepressant Agents: pages 63-86; Nova Publishers., ISBN: 978-1-62257-678-4

Full-text (6 Sources)

Download
75 Downloads
Available from
May 15, 2014